Track Fresenius SE & Co. KGaA — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Fresenius SE & Co. KGaA FREA.F · Stock Open Fresenius SE & Co. KGaA in new tab

10.70 EUR
P/E
15.51
EPS
0.69
Yield
2.47%
P/B
1.22
ROE
8.29
Beta
0.82
Loading chart...
Key Metrics
P/E15.51
EPS0.69
Book Value8.74
Price to Book1.22
Debt/Equity55.98
Growth
Revenue Growth0.05%
Earnings Growth0.17%
Dividend
Dividend Yield2.47%
Annual dividends0.26 EUR
Ex-Div. DateMay 26, 2026
Payout37.73%
5y avg Yield2.83%

DCF valuation

Model fair value for Fresenius SE & Co. KGaA (FREA.F)
Result
Sign in to run the valuation for FREA.F.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Fresenius SE & Co. KGaA Logo Fresenius SE & Co. KGaA Analysis (FREA.F)

Germany Health Care Official Website Stock

Is Fresenius SE & Co. KGaA a good investment? Fresenius SE & Co. KGaA (FREA.F) is currently trading at 10.70 EUR.

In terms of valuation, the stock trades at a P/E ratio of 15.51. This valuation is generally in line with the broader market.

For income investors, Fresenius SE & Co. KGaA pays a dividend yield of 2.47%. With a payout ratio of 38%, the dividend appears sustainable.

Investor FAQ

Does Fresenius SE & Co. KGaA pay a dividend?

Yes, it pays an annual dividend of 0.26 EUR (2.47% yield).

What asset class is Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA is classified as a Stock. You can compare it against 7 other assets in the "Related Symbols" list on this page.

Company Profile

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native, modular hospital information system that enables digitalization of clinical and administrative processes with AI integration. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.

Exchange Ticker
PNK (United States) FSNUY
FRA (Germany) FREA.F
MIL (Italy) FRE.MI
VIE (Austria) FRE.VI
STU (Germany) FREA.SG
MUN (Germany) FREN.MU
MEX (Mexico) FREN.MX
Trades
Dividend Yield
2.47%
5y avg 2.83%
Annual Dividends
0.26EUR
Next Ex. Div Date
May 26, 2026
Payout Ratio
37.73%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
▸2027
0.26 EUR
May 18, 2027 (estimated) 0.2625
▸2026
0.27 EUR
May 26, 2026 0.2725
▸2025
0.25 EUR
May 27, 2025 0.2531
▸2023
0.22 EUR
May 18, 2023 0.2215
▸2022
0.21 EUR
May 16, 2022 0.2149
▸2021
0.24 EUR
May 25, 2021 0.2397
▸2020
0.22 EUR
Aug. 31, 2020 0.2226
▸2019
0.20 EUR
May 20, 2019 0.1996
▸2018
0.20 EUR
May 22, 2018 0.1966
▸2017
0.15 EUR
May 15, 2017 0.1542
▸2016
0.14 EUR
May 11, 2016 0.1393
▸2015
0.11 EUR
May 18, 2015 0.1091
▸2014
0.13 EUR
May 14, 2014 0.1277
Upcoming Dividends
Name Payment Date Status Amount
Fresenius SE & Co. KGaA May 26, 2026 0.27246 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion